Search Results (36)
Click the Why column to see why an item matched the search.
| Match | Type | Why |
|---|
| Gaedigk, Andrea | Person |
Why?
|
| PharmVar GeneFocus: CYP2C9. | Academic Article |
Why?
|
| Cytochrome P-450 CYP2C9 | Concept |
Why?
|
| Cytochrome P-450 CYP2C9 Inducers | Concept |
Why?
|
| Cytochrome P-450 CYP2C9 Inhibitors | Concept |
Why?
|
| Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2C9 and Nonsteroidal Anti-Inflammatory Drugs. | Academic Article |
Why?
|
| Cytochrome P4502C9 (CYP2C9) allele frequencies in Canadian Native Indian and Inuit populations. | Academic Article |
Why?
|
| Efficiency of CYP2C9 genetic test representation for automated pharmacogenetic decision support. | Academic Article |
Why?
|
| Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2C9 and HLA-B Genotypes and Phenytoin Dosing: 2020 Update. | Academic Article |
Why?
|
| CYP2C9*61, a rare missense variant identified in a Puerto Rican patient with low warfarin dose requirements. | Academic Article |
Why?
|
| Chiral phase analysis of warfarin enantiomers in patient plasma in relation to CYP2C9 genotype. | Academic Article |
Why?
|
| Effects of fluvastatin and cigarette smoking on CYP2C9 activity measured using the probe S-warfarin. | Academic Article |
Why?
|
| Influence of CYP2C9 and VKORC1 on warfarin response during initiation of therapy. | Academic Article |
Why?
|
| Transcriptional regulation of human CYP2C genes: functional comparison of CYP2C9 and CYP2C18 promoter regions. | Academic Article |
Why?
|
| VKORC1 and CYP2C9 genotypes are predictors of warfarin-related outcomes in children. | Academic Article |
Why?
|